Next Article in Journal
Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis
Next Article in Special Issue
Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms
Previous Article in Journal
COVID-19 in Pulmonary Artery Hypertension (PAH) Patients: Observations from a Large PAH Center in New York City
Previous Article in Special Issue
Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Interesting Images

Incidental Finding of a PSMA-Positive Pancreatic Cancer in a Patient Suffering from a Metastasized PSMA-Positive Prostate Cancer

1
Department of Medicine II, University Hospital, 81377 LMU Munich, Germany
2
Department of Nuclear Medicine, University Hospital, 81377 LMU Munich, Germany
*
Author to whom correspondence should be addressed.
Diagnostics 2021, 11(1), 129; https://doi.org/10.3390/diagnostics11010129
Submission received: 22 December 2020 / Revised: 10 January 2021 / Accepted: 14 January 2021 / Published: 15 January 2021

Abstract

An 82-year-old man suffering from prostate cancer that was scheduled for a radioreceptor-ligand therapy (RLT) presented with jaundice to our service. An abdominal ultrasound (US) revealed obstructive extrahepatic cholestasis due to a solid lesion located in the uncinate process of the pancreas. The Prostate Specific Membrane Antigen (PSMA) PET/CT prior to RLT showed multilocular PSMA positive tumor lesions in the lymph nodes, the lung and the pancreas. On request of the cancer board, an Endoscopic Ultrasound (EUS)-guided Fine-Needle Aspiration (FNA) of the pancreatic mass was performed revealing invasive pancreatic ductal adenocarcinoma incompatible with a prostate cancer metastasis leading to the diagnosis of a PSMA positive pancreatic ductal adenocarcinoma.
Keywords: PSMA; pancreatic cancer; PET PSMA; pancreatic cancer; PET

Share and Cite

MDPI and ACS Style

Sirtl, S.; Todica, A.; Ilhan, H.; Zorniak, M.; Bartenstein, P.; Mayerle, J. Incidental Finding of a PSMA-Positive Pancreatic Cancer in a Patient Suffering from a Metastasized PSMA-Positive Prostate Cancer. Diagnostics 2021, 11, 129. https://doi.org/10.3390/diagnostics11010129

AMA Style

Sirtl S, Todica A, Ilhan H, Zorniak M, Bartenstein P, Mayerle J. Incidental Finding of a PSMA-Positive Pancreatic Cancer in a Patient Suffering from a Metastasized PSMA-Positive Prostate Cancer. Diagnostics. 2021; 11(1):129. https://doi.org/10.3390/diagnostics11010129

Chicago/Turabian Style

Sirtl, Simon, Andrei Todica, Harun Ilhan, Michal Zorniak, Peter Bartenstein, and Julia Mayerle. 2021. "Incidental Finding of a PSMA-Positive Pancreatic Cancer in a Patient Suffering from a Metastasized PSMA-Positive Prostate Cancer" Diagnostics 11, no. 1: 129. https://doi.org/10.3390/diagnostics11010129

APA Style

Sirtl, S., Todica, A., Ilhan, H., Zorniak, M., Bartenstein, P., & Mayerle, J. (2021). Incidental Finding of a PSMA-Positive Pancreatic Cancer in a Patient Suffering from a Metastasized PSMA-Positive Prostate Cancer. Diagnostics, 11(1), 129. https://doi.org/10.3390/diagnostics11010129

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop